Carlsmed, Inc. Common Stock CARL Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $56.44M+11.7% | $50.51M+12.9% | $44.75M+16.9% | $38.27M+18.6% | $32.27M+18.8% | ||
| $13.61M+9.1% | $12.47M+10.4% | $11.3M+13.6% | $9.94M+20.6% | $8.25M+15.9% | ||
| $42.83M+12.6% | $38.04M+13.7% | $33.46M+18.1% | $28.33M+17.9% | $24.02M+19.8% | ||
| 75.9%+0.6pp | 75.3%+0.6pp | 74.8%+0.7pp | 74%-0.4pp | 74.4%+0.6pp | ||
| $19.05M+11.9% | $17.02M+15.2% | $14.77M+2.9% | $14.36M+1.1% | $14.2M-0.7% | ||
| $38.59M+10.2% | $35.03M+14.5% | $30.6M+10.8% | $27.61M+12.2% | $24.61M+14.6% | ||
| $19.33M+16.7% | $16.57M+18.0% | $14.04M+27.0% | $11.05M+13.7% | $9.72M+15.8% | ||
| $76.96M+12.2% | $68.61M+15.5% | $59.41M+12.0% | $53.02M+9.3% | $48.53M+9.9% | ||
| $76.96M+12.2% | $68.61M+15.5% | $59.41M+12.0% | $53.02M+9.3% | $48.53M+9.9% | ||
| -$34.13M-11.6% | -$30.57M-17.8% | -$25.95M-5.1% | -$24.7M-0.7% | -$24.51M-1.6% | ||
| -60.5%+0.1pp | -60.5%-2.5pp | -58%+6.5pp | -64.5%+11.4pp | -76%+12.8pp | ||
| $1.38M-3.2% | $1.43M-3.2% | $1.48M-1.5% | $1.5M+2.6% | $1.46M+10.7% | ||
| $3.21M+18.9% | $2.7M+29.7% | $2.08M+36.8% | $1.52M-5.7% | $1.61M+21.2% | ||
| $1.53M+62.8% | $940K+343% | $212K+164% | -$333K-1,133% | -$27K+80.0% | ||
| -$32.6M-10.0% | -$29.63M-15.1% | -$25.74M-2.8% | -$25.03M-2.0% | -$24.54M-1.2% | ||
| -57.8%+0.9pp | -58.7%-1.2pp | -57.5%+7.9pp | -65.4%+10.6pp | -76%+13.2pp | ||
| —— | $584K— | —— | —— | —— | ||
| —— | —— | -$4.48+27.0% | -$6.14+1.3% | -$6.22-1.8% | ||
| —— | —— | -$4.48+27.0% | -$6.14+1.3% | -$6.22-1.8% | ||
| 66.7M+51.0% | 44.2M+29.8% | 34M+99.7% | 17M+3.3% | 16.5M— | ||
| 66.7M+51.0% | 44.2M+29.8% | 34M+99.7% | 17M+3.3% | 16.5M— | ||
| -$32.6M-10.0% | -$29.63M-15.1% | -$25.74M-2.8% | -$25.03M-2.0% | -$24.54M-1.2% | ||
| $1.53M+62.8% | $940K+343% | $212K+164% | -$333K-1,133% | -$27K+80.0% | ||
| -$34.13M-11.6% | -$30.57M-17.8% | -$25.95M-5.1% | -$24.7M-0.7% | -$24.51M-1.6% | ||
| -$33.79M-11.5% | -$30.29M-17.7% | -$25.73M-4.9% | -$24.52M— | —— | ||
| -$33.79M-11.5% | -$30.29M-17.7% | -$25.73M-4.9% | -$24.52M— | —— | ||
| -59.9%+0.1pp | -60%-2.5pp | -57.5%+6.6pp | -64.1%— | —— | ||
| -$34.13M-11.6% | -$30.57M-17.8% | -$25.95M-5.1% | -$24.7M-0.7% | -$24.51M-1.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Carlsmed, Inc. Common Stock's revenue?
- Carlsmed, Inc. Common Stock (CARL) generated $56.4M in revenue over the trailing twelve months, up 74.9% year over year.
- Is Carlsmed, Inc. Common Stock profitable?
- Carlsmed, Inc. Common Stock is not currently profitable: it reported a net loss of $32.6M over the trailing twelve months, a -57.8% net margin.
- What are Carlsmed, Inc. Common Stock's profit margins?
- Gross margin is 75.9% and operating margin is -60.5%, with a -57.8% net margin.
- What is Carlsmed, Inc. Common Stock's earnings per share?
- Carlsmed, Inc. Common Stock's diluted EPS over the trailing twelve months is $-3.66.
- Where does Carlsmed, Inc. Common Stock's income statement data come from?
- Every line is extracted from Carlsmed, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
